Example: Heart Attack

Clinical Trials Sponsored by Genitope Corporation

Total 6 results

NCT00510471

Terminated

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

Conditions: Non-Hodgkin's Lymphoma
NCT00302861

Terminated

A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Conditions: B-Cell Chronic Lymphocytic Leukemia
NCT00071955

Completed

Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma

Conditions: Lymphoma
NCT00017290

Unknown status

Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

Conditions: Lymphoma
NCT00574886

Completed

Idiotype Vaccine Following High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Patients With Lymphoma Who Had Failed Induction Chemotherapy

Conditions: Lymphoma
NCT00004198

Completed

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

Conditions: Lymphoma